Many High-Risk Patients with Breast Cancer Aren’t Getting Genetic Testing. Here’s Why.

February 7, 2017

(The Washington Post) – Doctors often fail to recommend genetic testing for breast-cancer patients, even those who are at high risk for mutations linked to ovarian and other cancers, according to a study published Tuesday. Researchers said the findings, which appear online in the Journal of the American Medical Association, are troubling because genetic tests can help guide women’s choice of treatments for existing disease, as well as point to ways to reduce the risk of future cancer. Women who have a dangerous mutation might choose to have more stringent screening or opt to have surgery before a cancer develops, they said.